<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00927654</url>
  </required_header>
  <id_info>
    <org_study_id>2008-002090-12</org_study_id>
    <nct_id>NCT00927654</nct_id>
  </id_info>
  <brief_title>Iloprost in High Risk Cardiac Surgical Patients</brief_title>
  <acronym>Ilocard</acronym>
  <official_title>Effect of Iloprost Inhalation Before and During Extracorporeal Circulation (ECC) on Perioperative Morbidity and Outcome in High Risk Cardiac Surgical Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ludwig-Maximilians - University of Munich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Algora</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Ludwig-Maximilians - University of Munich</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study effects of the intra operative, prophylactic inhalation of Iloprost (Ventavis)
      before and during extracorporal circulation on perioperative morbidity and outcome in high
      risk cardiac surgical patients is investigated in comparison to placebo.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2009</start_date>
  <completion_date type="Actual">March 2012</completion_date>
  <primary_completion_date type="Actual">March 2012</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Duration of post-operative artificial respiration after arrival on intensive care unit</measure>
    <time_frame>2-3 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>90 days lethality</measure>
    <time_frame>90 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">253</enrollment>
  <condition>Pulmonary Hypertension</condition>
  <arm_group>
    <arm_group_label>Iloprost</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Isotonic Sodium Chloride solution 0.9 %</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Iloprost (Ventavis)</intervention_name>
    <description>Twice 20 µg at day 0 (total dose 40 µg) intraoperatively</description>
    <arm_group_label>Iloprost</arm_group_label>
    <other_name>Ventavis</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Isotonic Sodium Chloride solution 0.9 % (placebo)</intervention_name>
    <description>Twice at day 0 intraoperatively</description>
    <arm_group_label>Isotonic Sodium Chloride solution 0.9 %</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  written informed consent

          -  for females of childbearing potential: negative pregnancy test

          -  patients, male or female, 18 to 85 years old

          -  elective open-heart surgery using heart-lung-machine

          -  patients with increased risk to suffer from perioperative right heart failure, i.e.,

               -  protracted surgery: multiple valvular transplant or expected bypass time
                  exceeding 120 min and/or

               -  patients with preoperative known pulmonary hypertension and/or

               -  patients with severe heart insufficiency (NYHA III or NYHA IV)

        Exclusion Criteria:

          -  patient not able to give consent

          -  pregnant or nursing patients

          -  Anamnestic known hypersensitivity to the used drug (Ventavis) and its ingredients or
             to drugs with a similar chemical structure

          -  blood clotting disorder requiring treatment

          -  trauma, intracerebral bleeding or apoplexy within the last 3 months prior to surgery

          -  primary or secondary immune deficiency (e.g., pretreatment with steroids, cytostatics)

          -  systemic infection

          -  lung disorder with impaired gas exchange

          -  lung transplantation

          -  cardiac transplantation

          -  implantation of LVAD (left ventricular assist device)

          -  fluoride ulcus disorder

          -  planned surgery in deep hypothermia and cardiac arrest

          -  subconscious and psychiatric disordered patients

          -  participation in another clinical trial within the last 30 days prior to study start
             and up to 30 days after end of study

          -  previous participation in this study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bernhard Zwissler, Prof.Dr.med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ludwig-Maximilians - University of Munich</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital of the university of Aachen</name>
      <address>
        <city>Aachen</city>
        <zip>52074</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Herz- und Diabeteszentrum NRW</name>
      <address>
        <city>Bad Oeynhausen</city>
        <zip>32545</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Deutsches Herzzentrum Berlin</name>
      <address>
        <city>Berlin</city>
        <zip>13353</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital of the university of Duesseldorf</name>
      <address>
        <city>Duesseldorf</city>
        <zip>40225</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital of the university of Frankfurt</name>
      <address>
        <city>Frankfurt</city>
        <zip>60590</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital of the university of munich</name>
      <address>
        <city>Munich</city>
        <zip>81377</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 17, 2009</study_first_submitted>
  <study_first_submitted_qc>June 24, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 25, 2009</study_first_posted>
  <last_update_submitted>January 4, 2013</last_update_submitted>
  <last_update_submitted_qc>January 4, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 7, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ludwig-Maximilians - University of Munich</investigator_affiliation>
    <investigator_full_name>Prof. Dr. med. B. Zwissler</investigator_full_name>
    <investigator_title>Director Clinic for Anesthesiology</investigator_title>
  </responsible_party>
  <keyword>Iloprost</keyword>
  <keyword>pulmonary hypertension</keyword>
  <keyword>cardio pulmonary morbidity</keyword>
  <keyword>high risk cardiac surgical patients</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Hypertension, Pulmonary</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Iloprost</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

